Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors
Lower baseline NK cell percentages are associated with improved OS and PFS in R/M-NPC patients undergoing PD-L1 inhibitor therapy.
Authors
- Yiyan Pei (ORCID: https://orcid.org/0000-0003-3293-6236)
- Jiayu Diao (ORCID: https://orcid.org/0000-0002-4646-7920)
- Junyou Ge (ORCID: https://orcid.org/0000-0002-6524-0078)
- Qing Yan (ORCID: https://orcid.org/0000-0002-7830-9126)
- Youneng Wei
- Xingchen Peng (ORCID: https://orcid.org/0000-0001-7042-718X)
- Ye Chen (ORCID: https://orcid.org/0000-0001-5317-4846)
- Zhigong Wei (ORCID: https://orcid.org/0000-0001-8112-9508)
Institutions
- Sichuan University (CN)
- Kelun Group (China) (CN)
- State Key Laboratory of Biotherapy
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1007/s00262-024-03885-1
- Citations
- 4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 4.18
Funders
- National Natural Science Foundation of China